NASDAQ Biotechnology (NBI)

Add to/Remove from a Portfolio  
3,694.4 +26.1    +0.71%
28/08 - Closed. Currency in USD ( Disclaimer )
Type: Index
Market: United States
# Components: 143

  • Volume: -
  • Open: 3,650.6
  • Day's Range: 3,640.1 - 3,696.1
Start Trading
NQ Biotechnology 3,694.4 +26.1 +0.71%
Add to/Remove from a Portfolio  

NQ Biotechnology Overview

Prev. Close3,694.4
Volume-
Day's Range3,640.1 - 3,696.1
Open3,650.6
Average Vol. (3m)-
52 wk Range2598.1 - 4194.9
1-Year Return27.71%

NASDAQ Biotechnology News & Analysis

Related Articles

Most Active Stocks

  Name Last Prev. High Low Chg. % Vol. Time
ARIAD 9.89 6.98 10.07 6.90 +41.69% 38.73M 28/08  
Gilead 107.78 107.99 108.79 106.78 -0.19% 10.76M 28/08  
Mylan 50.37 51.49 51.93 49.82 -2.18% 7.62M 28/08  
Exelixis Inc 6.05 6.09 6.17 5.96 -0.66% 4.77M 28/08  
Amgen 155.89 155.72 158.00 153.71 +0.11% 4.65M 28/08  
Celgene 124.04 123.04 124.44 121.87 +0.81% 4.60M 28/08  
Novavax 11.620 11.620 11.705 11.284 -0.86% 3.79M 28/08  
Arena 2.71 2.65 2.75 2.57 +2.26% 3.70M 28/08  
MannKind 3.920 3.910 3.920 3.771 +0.26% 3.69M 28/08  
The Medicines 33.64 31.75 34.40 32.48 +5.95% 2.84M 28/08  

Top Gainers

Name Last Chg. Chg. %
ARIAD 9.89 +2.91 +41.69%
Epizyme Inc 20.10 +2.60 +14.86%
Inovio 7.730 +0.750 +10.74%
Regulus 8.270 +0.790 +10.56%
Immunomedics 2.160 +0.200 +10.20%

Top Losers

Name Last Chg. Chg. %
ChemoCentryx 6.500 -0.390 -5.66%
Impax Labs 42.40 -1.57 -3.57%
Amphastar P 13.39 -0.42 -3.04%
Mylan 50.37 -1.12 -2.18%
Flamel 22.03 -0.46 -2.05%
Powered By

Follow Top Signal Providers

Account Nickname Net Profit P/L % Win % Weeks
SignalKING $37,014.90 457.37% 46.91% 250 Follow
SignalMAX $44,336.50 306.41% 69.22% 103 Follow
SignalWave $4,359.22 288.61% 93.95% 46 Follow
SignalPower $7,790.62 278.39% 71.98% 43 Follow
SignalAlpha $4,683.74 191.96% 67.88% 66 Follow

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
67%
Bearish
33%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Add Chart to Comment
NASDAQ Biotechnology
 
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
 
 

Successfully Reported

Thank you. This comment has been flagged for a moderator.
 
 
 
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.